Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17012455 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding
Condition: Dysfunctional Uterine Bleeding
Interventions: Drug: Medroxyprogesterone 17-Acetate;   Drug: medroxyprogesterone acetate

Indicates status has not been verified in more than two years